Khedmat Hossein, Fallahian Farahnaz, Abolghasemi Hassan, Hajibeigi Bashir, Attarchi Zohre, Alaeddini Farshid, Holisaz Mohammad Taghi, Pourali Masoumeh, Sharifi Shahin, Zarei Nasrin
Department of Internal Medicine, Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Mollasadra Ave.Tehran, IR, Iran.
World J Gastroenterol. 2007 Feb 14;13(6):889-94. doi: 10.3748/wjg.v13.i6.889.
To determine serum gamma-glutamyltransferase (GGT), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) activity, and to assess their correlation with demographic and clinical findings in healthy blood donors.
This cross-sectional study was performed in 934 male blood donors, aged 18 to 68 years, who consecutively attended Tehran blood transfusion service in 2006. All participants were seronegative for HBV or HCV infections, non alcohol users, and all underwent a standard interview and anthropometric tests. Clinical and biochemical parameters including AST, ALT, and GGT activities were determined. Patients taking drugs known to cause hepatic fat deposition were excluded. For AST, ALT, and GGT variables, we used 33.33 and 66.66 percentiles, so that each of them was divided into three tertiles.
Mean AST, ALT, and GGT activities were 25.26 +/- 12.58 U/L (normal range 5-35 U/L), 33.13 +/- 22.98 (normal range 5-35 U/L), and 25.11 +/- 18.32 (normal range 6-37 U/L), respectively. By univariate analyses, there were significant associations between increasing AST, ALT, or GGT tertiles and age, body weight, body mass index, and waist and hip circumferences (P<0.05). By multiple linear regression analyses, ALT was found to be positively correlated with dyslipidemia (B=6.988, P=0.038), whereas ALT and AST were negatively correlated with age. AST, ALT, and GGT levels had positive correlation with family history of liver disease (B=15.763, P<0.001), (B=32.345, P<0.001), (B=24.415, P<0.001), respectively.
Although we did not determine the cutoffs of the upper normal limits for AST, ALT, and GGT levels, we would suggest screening asymptomatic patients with dyslipidemia and also subjects with a family history of liver disease.
测定血清γ-谷氨酰转移酶(GGT)、丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)活性,并评估其与健康献血者人口统计学和临床结果的相关性。
本横断面研究纳入了934名年龄在18至68岁之间的男性献血者,他们于2006年连续前往德黑兰输血服务中心。所有参与者乙肝或丙肝感染血清学阴性,非饮酒者,均接受了标准访谈和人体测量测试。测定了包括AST、ALT和GGT活性在内的临床和生化参数。排除服用已知会导致肝脏脂肪沉积药物的患者。对于AST、ALT和GGT变量,我们使用了第33.33和66.66百分位数,从而将它们各自分为三个三分位数。
AST、ALT和GGT的平均活性分别为25.26±12.58 U/L(正常范围5 - 35 U/L)、33.13±22.98(正常范围5 - 35 U/L)和25.11±18.32(正常范围6 - 37 U/L)。通过单因素分析,AST、ALT或GGT三分位数升高与年龄、体重、体重指数以及腰围和臀围之间存在显著关联(P<0.05)。通过多元线性回归分析,发现ALT与血脂异常呈正相关(B = 6.988,P = 0.038),而ALT和AST与年龄呈负相关。AST、ALT和GGT水平与肝病家族史呈正相关(B = 15.763,P<0.001)、(B = 32.345,P<0.001)、(B = 24.415,P<0.001)。
尽管我们未确定AST、ALT和GGT水平的正常上限临界值,但我们建议对无症状血脂异常患者以及有肝病家族史的受试者进行筛查。